Ribstein J, Cristol J P, Elkik F, Mimran A
Department of Medicine, Hôpital Lapeyronie, CHU, Montpellier, France.
J Hypertens Suppl. 1985 Dec;3(3):S165-7.
The acute hypotensive and renal effects of the calcium antagonist tiapamil, a verapamil derivative, were studied in nine normal and 13 essential hypertensive subjects undergoing water diuresis. Tiapamil decreased mean arterial pressure slightly in normotensive subjects and more markedly in hypertensive patients (-6 +/- 1 versus -10 +/- 2%). The effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) were unaffected in both groups. A striking natriuresis was observed selectively in the hypertensive group (+344 +/- 84 versus +42 +/- 22 mmol/min) and was associated with an increase in the calculated fractional distal delivery of sodium and uric acid excretion rate. Plasma aldosterone concentration decreased moderately and to the same extent in both groups. In conclusion, tiapamil induced a marked natriuresis in essential hypertensive patients, despite a decrease in blood pressure, and in the absence of renal vasodilatation; this may suggest the existence in essential hypertension of a calcium-linked abnormality in the renal proximal tubular handling of sodium.
在9名正常受试者和13名正在进行水利尿的原发性高血压患者中,研究了维拉帕米衍生物钙拮抗剂替帕米的急性降压和对肾脏的影响。替帕米使血压正常受试者的平均动脉压略有下降,而使高血压患者的平均动脉压下降更为明显(分别为-6±1%和-10±2%)。两组的有效肾血浆流量(ERPF)和肾小球滤过率(GFR)均未受影响。在高血压组中选择性地观察到显著的利钠作用(分别为+344±84和+42±22 mmol/分钟),并且与计算得出的远端钠排泄分数增加和尿酸排泄率增加相关。两组血浆醛固酮浓度均适度下降且下降程度相同。总之,尽管血压下降且不存在肾血管舒张,替帕米仍在原发性高血压患者中诱导了显著的利钠作用;这可能提示原发性高血压患者存在肾脏近端小管钠处理中与钙相关的异常。